Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1281)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,260
Price
$544.59
Total Value
$686.19K
Shares Held After
325,723
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
783
Price
$543.54
Total Value
$425.59K
Shares Held After
326,983
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
918
Price
$542.56
Total Value
$498.07K
Shares Held After
327,766
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,239
Price
$541.66
Total Value
$671.12K
Shares Held After
328,684
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,028
Price
$540.50
Total Value
$555.63K
Shares Held After
329,923
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
931
Price
$539.50
Total Value
$502.28K
Shares Held After
330,951
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
655
Price
$538.62
Total Value
$352.80K
Shares Held After
331,882
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
905
Price
$537.43
Total Value
$486.37K
Shares Held After
332,537
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
501
Price
$536.26
Total Value
$268.67K
Shares Held After
333,442
% of Holdings
0.2%
BICYCLE THERAPEUTICS PLC (BCYC)
Thompson Travis Alvin — Chief Financial Officer
Shares
79
Price
$3.57
Total Value
$282.03
Shares Held After
64,449
% of Holdings
0.1%
Artiva Biotherapeutics, Inc. (ARTV)
Aslan Fred — Director
Shares
61,696
Price
$6.84
Total Value
$421.83K
Shares Held After
1,543,069
% of Holdings
3.8%
Artiva Biotherapeutics, Inc. (ARTV)
Banerjee Subhashis — Chief Medical Officer
Shares
1,099
Price
$6.84
Total Value
$7.51K
Shares Held After
169,848
% of Holdings
0.6%
Artiva Biotherapeutics, Inc. (ARTV)
Horan Christopher — Chief Tech Operations Officer
Shares
10,340
Price
$6.84
Total Value
$70.70K
Shares Held After
312,744
% of Holdings
3.2%
Artiva Biotherapeutics, Inc. (ARTV)
Bush Jennifer — COO, CLO, Compliance Officer
Shares
8,370
Price
$6.84
Total Value
$57.23K
Shares Held After
366,159
% of Holdings
2.2%
Monte Rosa Therapeutics, Inc. (GLUE)
Bowen Matthew — Principal Accounting Officer
Shares
13
Price
$10.56
Total Value
$137.28
Shares Held After
25,891
% of Holdings
0.1%
Anteris Technologies Global Corp. (AVR)
L1 Capital Pty Ltd — 10% Owner
Shares
648,455
Price
$7.51
Total Value
$4.87M
Shares Held After
12,778,380
% of Holdings
5.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
5,182
Price
$29.67
Total Value
$153.75K
Shares Held After
377,802
% of Holdings
1.4%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
6,699
Price
$28.82
Total Value
$193.07K
Shares Held After
382,984
% of Holdings
1.7%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Reynoso Jamie L. — CEO, Medicare Advantage
Shares
8,750
Price
$4.42
Total Value
$38.67K
Shares Held After
2,794,696
% of Holdings
0.3%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
1,694
Price
$2.06
Total Value
$3.49K
Shares Held After
2,858,657
% of Holdings
0.1%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
18,182
Price
$1.33
Total Value
$24.18K
Shares Held After
935,021
% of Holdings
1.9%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research&Investments
Shares
4,126
Price
$57.10
Total Value
$235.59K
Shares Held After
0
% of Holdings
100.0%
Medline Inc. (MDLN)
GIC Private Ltd — 10% Owner
Shares
7,146,941
Price
$34.33
Total Value
$245.35M
Shares Held After
84,408,506
% of Holdings
7.8%
Medline Inc. (MDLN)
GIC Private Ltd — 10% Owner
Shares
2,570,999
Price
$35.35
Total Value
$90.88M
Shares Held After
20,231,483
% of Holdings
11.3%
SI-BONE, Inc. (SIBN)
PISETSKY MICHAEL A. — SVP, Ops&Adm/Chief Legal Ofr
Shares
34
Price
$18.14
Total Value
$616.76
Shares Held After
270,517
% of Holdings
0.0%
SI-BONE, Inc. (SIBN)
PISETSKY MICHAEL A. — SVP, Ops&Adm/Chief Legal Ofr
Shares
1,799
Price
$18.14
Total Value
$32.64K
Shares Held After
270,551
% of Holdings
0.7%
SI-BONE, Inc. (SIBN)
PISETSKY MICHAEL A. — SVP, Ops&Adm/Chief Legal Ofr
Shares
1,300
Price
$18.20
Total Value
$23.66K
Shares Held After
272,350
% of Holdings
0.5%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Op&Financial Officer
Shares
1,758
Price
$18.19
Total Value
$31.98K
Shares Held After
219,966
% of Holdings
0.8%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Op&Financial Officer
Shares
1,560
Price
$18.17
Total Value
$28.34K
Shares Held After
221,724
% of Holdings
0.7%
ImmunityBio, Inc. (IBRX)
Cohen Cheryl — Director
Shares
81,056
Price
$10.50
Total Value
$851.09K
Shares Held After
100,309
% of Holdings
44.7%
Pelthos Therapeutics Inc. (PTHS)
Pauls Matthew — Director
Shares
786
Price
$21.00
Total Value
$16.51K
Shares Held After
13,578
% of Holdings
5.5%
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
558
Price
$20.72
Total Value
$11.56K
Shares Held After
80,484
% of Holdings
0.7%
Pelthos Therapeutics Inc. (PTHS)
Greenleaf Peter — Director
Shares
797
Price
$21.17
Total Value
$16.87K
Shares Held After
23,087
% of Holdings
3.3%
BICYCLE THERAPEUTICS PLC (BCYC)
Swanton Robert Charles — Director
Shares
3,431
Price
$3.47
Total Value
$11.91K
Shares Held After
15,782
% of Holdings
17.9%
BICYCLE THERAPEUTICS PLC (BCYC)
Lee Kevin — Director
Shares
6,167
Price
$3.47
Total Value
$21.40K
Shares Held After
597,504
% of Holdings
1.0%
Butterfly Network, Inc. (BFLY)
Carlson Megan — CAO and SVP, Finance
Shares
10,114
Price
$8.74
Total Value
$88.45K
Shares Held After
401,971
% of Holdings
2.5%
BICYCLE THERAPEUTICS PLC (BCYC)
Skynner Michael — CHIEF SCIENTIFIC OFFICER
Shares
1,942
Price
$3.47
Total Value
$6.74K
Shares Held After
155,229
% of Holdings
1.2%
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
1,094
Price
$3.47
Total Value
$3.80K
Shares Held After
89,958
% of Holdings
1.2%
BICYCLE THERAPEUTICS PLC (BCYC)
Hannay Michael Charles Ferguson — CHIEF PROD&SUPPLY CHAIN OFF
Shares
1,572
Price
$3.47
Total Value
$5.45K
Shares Held After
92,803
% of Holdings
1.7%
OCULAR THERAPEUTIX, INC (OCUL)
Heier Jeffrey S. — Chief Scientific Officer
Shares
10,869
Price
$7.05
Total Value
$76.63K
Shares Held After
307,457
% of Holdings
3.4%
OCULAR THERAPEUTIX, INC (OCUL)
Kaiser Peter — Chief Development Officer
Shares
9,990
Price
$7.05
Total Value
$70.43K
Shares Held After
254,388
% of Holdings
3.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
17
Price
$307.74
Total Value
$5.23K
Shares Held After
31,854
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
235
Price
$307.19
Total Value
$72.19K
Shares Held After
31,871
% of Holdings
0.7%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
404
Price
$306.18
Total Value
$123.70K
Shares Held After
32,106
% of Holdings
1.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
1,535
Price
$304.52
Total Value
$467.43K
Shares Held After
32,510
% of Holdings
4.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
1,976
Price
$303.54
Total Value
$599.80K
Shares Held After
34,045
% of Holdings
5.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
833
Price
$302.51
Total Value
$251.99K
Shares Held After
36,021
% of Holdings
2.3%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,500
Price
$16.00
Total Value
$40.00K
Shares Held After
27,000
% of Holdings
9.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
SUPRAN BRYAN — EVP, CLO and Secretary
Shares
1,758
Price
$226.88
Total Value
$398.86K
Shares Held After
12,807
% of Holdings
12.1%
BICYCLE THERAPEUTICS PLC (BCYC)
Thompson Travis Alvin — Chief Financial Officer
Shares
893
Price
$3.47
Total Value
$3.10K
Shares Held After
64,528
% of Holdings
1.4%
Showing 151–200 of 1281 transactions (page 4 of 26)